Sign Up to like & get
recommendations!
1
Published in 2022 at "RSC Advances"
DOI: 10.1039/d2ra05751d
Abstract: The “RAS-RAF-MEK-ERK” pathway is an important signaling pathway in melanoma. BRAFV600E (70–90%) is the most common mutation in this pathway. BRAF inhibitors have four types of conformers: type I (αC-IN/DFG-IN), type II (αC-IN/DFG-OUT), type I1/2…
read more here.
Keywords:
brafv600e inhibitors;
brafv600e;
pyrimidine sulfonamide;
dfg ... See more keywords